| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.40e-06 | 118 | 169 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.38e-05 | 18 | 169 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.65e-05 | 28 | 169 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RALGDS RAPGEF6 MYCBP2 ITSN1 ALS2 RASGRP1 ITSN2 DOCK7 SPATA13 | 1.60e-04 | 231 | 169 | 9 | GO:0005085 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.63e-04 | 37 | 169 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.18e-04 | 70 | 169 | 5 | GO:0003777 | |
| MousePheno | CNS inflammation | 1.28e-05 | 54 | 135 | 6 | MP:0006082 | |
| Domain | Homeodomain-like | GSX1 FMO1 DBX2 LCORL TLX3 NKX2-3 GSX2 GBX1 RABGAP1 HMX1 HMX2 TLX1 LHX2 ZZZ3 UBTF ZFHX2 NKX2-5 ZFHX3 NKX6-1 SNAPC4 | 2.35e-11 | 332 | 169 | 20 | IPR009057 |
| Domain | Homeobox_metazoa | GSX1 DBX2 TLX3 NKX2-3 GSX2 GBX1 HMX1 HMX2 TLX1 NKX2-5 NKX6-1 | 5.39e-10 | 90 | 169 | 11 | IPR020479 |
| Domain | - | GSX1 DBX2 TLX3 NKX2-3 GSX2 GBX1 RABGAP1 HMX1 HMX2 TLX1 LHX2 ZZZ3 ZFHX2 NKX2-5 ZFHX3 NKX6-1 SNAPC4 | 8.41e-10 | 283 | 169 | 17 | 1.10.10.60 |
| Domain | Homeobox_CS | GSX1 DBX2 TLX3 NKX2-3 GSX2 GBX1 HMX1 HMX2 TLX1 LHX2 ZFHX2 NKX2-5 ZFHX3 NKX6-1 | 1.54e-09 | 186 | 169 | 14 | IPR017970 |
| Domain | Homeobox | GSX1 DBX2 TLX3 NKX2-3 GSX2 GBX1 HMX1 HMX2 TLX1 LHX2 ZFHX2 NKX2-5 ZFHX3 NKX6-1 | 2.92e-08 | 234 | 169 | 14 | PF00046 |
| Domain | HOMEOBOX_1 | GSX1 DBX2 TLX3 NKX2-3 GSX2 GBX1 HMX1 HMX2 TLX1 LHX2 ZFHX2 NKX2-5 ZFHX3 NKX6-1 | 3.25e-08 | 236 | 169 | 14 | PS00027 |
| Domain | HOX | GSX1 DBX2 TLX3 NKX2-3 GSX2 GBX1 HMX1 HMX2 TLX1 LHX2 ZFHX2 NKX2-5 ZFHX3 NKX6-1 | 3.43e-08 | 237 | 169 | 14 | SM00389 |
| Domain | HOMEOBOX_2 | GSX1 DBX2 TLX3 NKX2-3 GSX2 GBX1 HMX1 HMX2 TLX1 LHX2 ZFHX2 NKX2-5 ZFHX3 NKX6-1 | 3.81e-08 | 239 | 169 | 14 | PS50071 |
| Domain | Homeobox_dom | GSX1 DBX2 TLX3 NKX2-3 GSX2 GBX1 HMX1 HMX2 TLX1 LHX2 ZFHX2 NKX2-5 ZFHX3 NKX6-1 | 3.81e-08 | 239 | 169 | 14 | IPR001356 |
| Domain | NPIP | 1.07e-07 | 14 | 169 | 5 | IPR009443 | |
| Domain | EF-hand-dom_pair | LPCAT1 SPTAN1 ITSN1 CAPN1 LCP1 RASGRP1 MRPS26 ITSN2 PLCL2 PKD2 DMD | 6.29e-05 | 287 | 169 | 11 | IPR011992 |
| Domain | DUF4537 | 8.14e-05 | 2 | 169 | 2 | IPR032770 | |
| Domain | DUF4537 | 8.14e-05 | 2 | 169 | 2 | PF15057 | |
| Domain | PH_13 | 8.14e-05 | 2 | 169 | 2 | PF16652 | |
| Domain | - | 1.36e-04 | 261 | 169 | 10 | 1.10.238.10 | |
| Domain | RA | 1.68e-04 | 31 | 169 | 4 | SM00314 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.46e-04 | 14 | 169 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.46e-04 | 14 | 169 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.46e-04 | 14 | 169 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.46e-04 | 14 | 169 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.46e-04 | 14 | 169 | 3 | IPR011704 | |
| Domain | MT | 2.46e-04 | 14 | 169 | 3 | PF12777 | |
| Domain | AAA_8 | 2.46e-04 | 14 | 169 | 3 | PF12780 | |
| Domain | AAA_5 | 2.46e-04 | 14 | 169 | 3 | PF07728 | |
| Domain | DHC_fam | 3.06e-04 | 15 | 169 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 3.06e-04 | 15 | 169 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.06e-04 | 15 | 169 | 3 | IPR004273 | |
| Domain | RA | 3.38e-04 | 37 | 169 | 4 | PS50200 | |
| Domain | Myosin_head_motor_dom | 3.76e-04 | 38 | 169 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.76e-04 | 38 | 169 | 4 | PS51456 | |
| Domain | Myosin_head | 3.76e-04 | 38 | 169 | 4 | PF00063 | |
| Domain | MYSc | 3.76e-04 | 38 | 169 | 4 | SM00242 | |
| Domain | HTH_motif | 4.03e-04 | 69 | 169 | 5 | IPR000047 | |
| Domain | RA_dom | 4.59e-04 | 40 | 169 | 4 | IPR000159 | |
| Domain | EF_HAND_1 | 5.50e-04 | 204 | 169 | 8 | PS00018 | |
| Domain | EFh | 5.95e-04 | 158 | 169 | 7 | SM00054 | |
| Domain | RCC1 | 7.41e-04 | 20 | 169 | 3 | PF00415 | |
| Domain | RasGEFN | 7.41e-04 | 20 | 169 | 3 | SM00229 | |
| Domain | PKD_2 | 8.00e-04 | 5 | 169 | 2 | IPR003915 | |
| Domain | RasGEF_N | 8.59e-04 | 21 | 169 | 3 | PF00618 | |
| Domain | RCC1_1 | 8.59e-04 | 21 | 169 | 3 | PS00625 | |
| Domain | RCC1_2 | 8.59e-04 | 21 | 169 | 3 | PS00626 | |
| Domain | RCC1_3 | 8.59e-04 | 21 | 169 | 3 | PS50012 | |
| Domain | - | 9.88e-04 | 22 | 169 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 9.88e-04 | 22 | 169 | 3 | IPR000408 | |
| Domain | Ras-like_Gua-exchang_fac_N | 9.88e-04 | 22 | 169 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 9.88e-04 | 22 | 169 | 3 | PS50212 | |
| Domain | SANT | 1.08e-03 | 50 | 169 | 4 | SM00717 | |
| Domain | RCC1/BLIP-II | 1.13e-03 | 23 | 169 | 3 | IPR009091 | |
| Domain | BRK | 1.19e-03 | 6 | 169 | 2 | SM00592 | |
| Domain | BRK_domain | 1.19e-03 | 6 | 169 | 2 | IPR006576 | |
| Domain | BRK | 1.19e-03 | 6 | 169 | 2 | PF07533 | |
| Domain | EF_HAND_2 | 1.23e-03 | 231 | 169 | 8 | PS50222 | |
| Domain | SANT/Myb | 1.25e-03 | 52 | 169 | 4 | IPR001005 | |
| Domain | EF_hand_dom | 1.26e-03 | 232 | 169 | 8 | IPR002048 | |
| Domain | Arm_3 | 1.66e-03 | 7 | 169 | 2 | PF16186 | |
| Domain | Importing_su_alpha | 1.66e-03 | 7 | 169 | 2 | IPR024931 | |
| Domain | IBB | 1.66e-03 | 7 | 169 | 2 | PF01749 | |
| Domain | Arm_3 | 1.66e-03 | 7 | 169 | 2 | IPR032413 | |
| Domain | DHC_N1 | 2.20e-03 | 8 | 169 | 2 | PF08385 | |
| Domain | IBB | 2.20e-03 | 8 | 169 | 2 | PS51214 | |
| Domain | Dynein_heavy_dom-1 | 2.20e-03 | 8 | 169 | 2 | IPR013594 | |
| Domain | RASGEF_CAT | 2.24e-03 | 29 | 169 | 3 | PS50009 | |
| Domain | Spectrin_repeat | 2.24e-03 | 29 | 169 | 3 | IPR002017 | |
| Domain | RasGEF | 2.47e-03 | 30 | 169 | 3 | PF00617 | |
| Domain | - | 2.47e-03 | 30 | 169 | 3 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 2.47e-03 | 30 | 169 | 3 | IPR001895 | |
| Domain | RasGEF | 2.47e-03 | 30 | 169 | 3 | SM00147 | |
| Domain | Ras_GEF_dom | 2.47e-03 | 30 | 169 | 3 | IPR023578 | |
| Domain | Semap_dom | 2.72e-03 | 31 | 169 | 3 | IPR001627 | |
| Domain | SEMA | 2.72e-03 | 31 | 169 | 3 | PS51004 | |
| Domain | Arm | 2.72e-03 | 31 | 169 | 3 | PF00514 | |
| Domain | Sema | 2.72e-03 | 31 | 169 | 3 | SM00630 | |
| Domain | Sema | 2.72e-03 | 31 | 169 | 3 | PF01403 | |
| Domain | HTH_MYB | 2.81e-03 | 9 | 169 | 2 | PS51294 | |
| Domain | Importin-a_IBB | 2.81e-03 | 9 | 169 | 2 | IPR002652 | |
| Domain | Myb_dom | 2.81e-03 | 9 | 169 | 2 | IPR017930 | |
| Domain | Helicase_C | 2.89e-03 | 107 | 169 | 5 | PF00271 | |
| Domain | HELICc | 2.89e-03 | 107 | 169 | 5 | SM00490 | |
| Domain | Plexin_repeat | 2.98e-03 | 32 | 169 | 3 | IPR002165 | |
| Domain | SPEC | 2.98e-03 | 32 | 169 | 3 | SM00150 | |
| Domain | PSI | 2.98e-03 | 32 | 169 | 3 | PF01437 | |
| Domain | Spectrin/alpha-actinin | 2.98e-03 | 32 | 169 | 3 | IPR018159 | |
| Domain | Helicase_C | 3.01e-03 | 108 | 169 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 3.13e-03 | 109 | 169 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.13e-03 | 109 | 169 | 5 | PS51192 | |
| Domain | DEXDc | 3.13e-03 | 109 | 169 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.26e-03 | 110 | 169 | 5 | IPR014001 | |
| Domain | EF-hand_4 | 3.49e-03 | 10 | 169 | 2 | PF12763 | |
| Domain | RhoGEF | 3.73e-03 | 70 | 169 | 4 | PF00621 | |
| Domain | DH_2 | 3.73e-03 | 70 | 169 | 4 | PS50010 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.85e-03 | 35 | 169 | 3 | IPR002464 | |
| Domain | - | 3.92e-03 | 71 | 169 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 3.92e-03 | 71 | 169 | 4 | IPR000219 | |
| Domain | RA | 4.17e-03 | 36 | 169 | 3 | PF00788 | |
| Domain | PKD_channel | 4.24e-03 | 11 | 169 | 2 | PF08016 | |
| Domain | EH | 4.24e-03 | 11 | 169 | 2 | PS50031 | |
| Domain | EH | 4.24e-03 | 11 | 169 | 2 | SM00027 | |
| Domain | PKD1_2_channel | 4.24e-03 | 11 | 169 | 2 | IPR013122 | |
| Domain | EH_dom | 4.24e-03 | 11 | 169 | 2 | IPR000261 | |
| Pubmed | ZSWIM8 DDX31 MYO1C MYCBP2 SPTAN1 CAPN1 COPB2 CHD7 HEATR1 LCP1 WDR43 SART1 RIF1 IARS2 DDX46 GTF2I UBTF XRN1 DOCK7 HERC5 | 1.58e-10 | 653 | 176 | 20 | 22586326 | |
| Pubmed | RAPGEF6 MYCBP2 LCORL LRRC49 APC CHD7 RABGAP1 MCCC1 KIF20B MAP7D1 GTF2I ZZZ3 XRN1 DOCK7 ZFHX3 CHD6 | 4.96e-10 | 418 | 176 | 16 | 34709266 | |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 6.34e-10 | 4 | 176 | 4 | 18055785 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | GSX1 HIVEP2 DBX2 LCORL TLX3 NKX2-3 GSX2 GBX1 HMX1 HMX2 ATF2 TLX1 THAP2 THAP4 LHX2 ZZZ3 UBTF ZFHX2 NKX2-5 ZFHX3 NKX6-1 SNAPC4 | 1.47e-09 | 908 | 176 | 22 | 19274049 |
| Pubmed | RPL31 DDX31 MYO1C SPTAN1 LRRC49 TLX3 COPB2 CHD7 PSMD11 MCCC1 TLX1 LHX2 KMT2C RIF1 MAP7D1 GTF2I ZZZ3 PRCC UBTF MRPS26 BANP XRN1 NKX2-5 ZFHX3 CHD6 RPA1 SLX4 | 3.84e-09 | 1429 | 176 | 27 | 35140242 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 DDX31 DYNC2H1 ITSN1 APC EXOC3 KPNA6 CHD7 RABGAP1 NUP58 MCCC1 KIF20B GTF2F1 ZZZ3 BANP SLX4 | 6.05e-08 | 588 | 176 | 16 | 38580884 |
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 10491193 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL31 AUP1 TLX3 CHD7 HEATR1 MCCC1 ATF2 DDB2 EXOSC2 WDR43 SART1 THAP4 KMT2C RIF1 MSANTD3 MAP7D1 DDX46 GTF2I ZZZ3 UBTF BANP CHD6 RPA1 | 1.83e-07 | 1294 | 176 | 23 | 30804502 |
| Pubmed | RALGDS HIVEP2 HLA-B SPTAN1 ITSN1 APC KPNA6 NUP58 KMT2C RIF1 ITSN2 CHD6 TNFAIP3 DMD | 2.11e-07 | 486 | 176 | 14 | 20936779 | |
| Pubmed | Determination of genetic predisposition to patent ductus arteriosus in preterm infants. | 3.32e-07 | 129 | 176 | 8 | 19336370 | |
| Pubmed | TRAF2 MYO1C SPTAN1 INSRR APC MCCC1 PPL SART1 PRCC EEA1 RPA1 ACAP2 | 3.47e-07 | 360 | 176 | 12 | 33111431 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL31 DDX31 MYCBP2 COPB2 HEATR1 EXOSC2 KIF20B WDR43 SART1 RIF1 DDX46 MB21D2 UBTF XRN1 DGCR8 TOP3B HERC5 | 3.63e-07 | 759 | 176 | 17 | 35915203 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL31 TRAF2 MYO1C MYCBP2 AUP1 SPTAN1 CAPN1 COPB2 EXOC3 CHD7 PSMD11 HEATR1 MCCC1 KIF20B SART1 RIF1 MAP7D1 GTF2I UBTF XRN1 RPL22L1 RPA1 DHX34 | 3.98e-07 | 1353 | 176 | 23 | 29467282 |
| Pubmed | 4.37e-07 | 13 | 176 | 4 | 22159578 | ||
| Pubmed | MED13L KIF20B FANCG RIF1 MSANTD3 DDX46 GTF2I ZZZ3 PRCC RPL22L1 DGCR8 RPA1 SLX4 | 6.08e-07 | 453 | 176 | 13 | 29656893 | |
| Pubmed | 6.10e-07 | 14 | 176 | 4 | 9373155 | ||
| Pubmed | Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain. | 1.10e-06 | 16 | 176 | 4 | 15629702 | |
| Pubmed | MYO1C SPTAN1 KPNA6 LCP1 KIF20B SART1 RIF1 GTF2F1 DDX46 GTF2I ZZZ3 PRCC DOCK7 | 2.07e-06 | 506 | 176 | 13 | 30890647 | |
| Pubmed | RPL31 MYO1C AUP1 APC MCCC1 PPL SART1 RIF1 IARS2 GTF2I XRN1 PKLR DOCK7 ZFHX3 DGCR8 SCLT1 | 2.41e-06 | 777 | 176 | 16 | 35844135 | |
| Pubmed | ZSWIM8 TRAF2 HIVEP2 HLA-B MYCBP2 SPTAN1 ITSN1 APC KPNA6 TRIM68 NUP58 MED13L ADAM22 THAP4 LRRCC1 CHD6 DGCR8 MGAT5B RAB5B SLX4 DOP1B | 2.46e-06 | 1285 | 176 | 21 | 35914814 | |
| Pubmed | 2.52e-06 | 6 | 176 | 3 | 20518497 | ||
| Pubmed | 2.52e-06 | 6 | 176 | 3 | 17699751 | ||
| Pubmed | 3.55e-06 | 21 | 176 | 4 | 17321515 | ||
| Pubmed | 3.55e-06 | 21 | 176 | 4 | 15930101 | ||
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 3.55e-06 | 21 | 176 | 4 | 25249183 | |
| Pubmed | MYH2 MYH3 TTC24 MYO1C SPTAN1 ITSN1 HEATR1 LCP1 PPL SART1 MAP7D1 ITSN2 XRN1 CHD6 EEA1 DMD KIAA2012 DNAH6 DNAH8 TOP3B SPATA13 BAHCC1 | 4.21e-06 | 1442 | 176 | 22 | 35575683 | |
| Pubmed | Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. | 4.39e-06 | 7 | 176 | 3 | 20448643 | |
| Pubmed | 4.72e-06 | 130 | 176 | 7 | 19386638 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | CAPN1 PSMD11 HEATR1 MED13L LCP1 PPL UBTF MRPS26 SEMA3B XRN1 DOCK7 SERPINC1 DGCR8 RPA1 RAB5A | 5.34e-06 | 732 | 176 | 15 | 34732716 |
| Pubmed | 5.68e-06 | 250 | 176 | 9 | 33536335 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | KPNA5 MYH2 MYH3 LPCAT1 MYO1C AUP1 SPTAN1 COPB2 KPNA6 PSMD11 UBTF SERPINC1 RAB5A RAB5B | 6.03e-06 | 647 | 176 | 14 | 26618866 |
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 22585859 | ||
| Pubmed | RPL31 DDX31 HEATR1 LCP1 EXOSC2 WDR43 RIF1 MAP7D1 GTF2I ODR4 DGCR8 HERC5 | 7.24e-06 | 483 | 176 | 12 | 36912080 | |
| Pubmed | ALS2 MED13L MAP7D1 LRFN2 ITSN2 PLCL2 DOCK7 CHD6 CROCC SPATA13 DOP1B | 8.03e-06 | 407 | 176 | 11 | 12693553 | |
| Pubmed | 1.02e-05 | 27 | 176 | 4 | 20081190 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 21525013 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | GSX1 HIVEP2 TLX3 NKX2-3 APC GSX2 ATF2 TLX1 LHX2 GTF2F1 GTF2I ZZZ3 UBTF NKX2-5 TNFAIP3 SNAPC4 | 1.10e-05 | 877 | 176 | 16 | 20211142 |
| Pubmed | 1.18e-05 | 28 | 176 | 4 | 30277474 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL31 DDX31 MYO1C AUP1 HEATR1 MCCC1 EXOSC2 KIF20B WDR43 SART1 RIF1 GTF2I UBTF DGCR8 RPA1 RAB5A RAB5B | 1.25e-05 | 989 | 176 | 17 | 36424410 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | DDX31 LCORL CHD7 EXOSC2 KIF20B WDR43 RIF1 GTF2I UBTF NKAPD1 CHD6 SNAPC4 RPA1 | 1.48e-05 | 608 | 176 | 13 | 36089195 |
| Pubmed | The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis. | 1.49e-05 | 10 | 176 | 3 | 25911380 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 HIVEP2 MYO1C MYCBP2 DYNC2H1 APC PSMD11 DDB2 SART1 MAP7D1 GTF2I MRPS26 PKLR DOCK7 RPL22L1 TNFAIP3 SCLT1 | 1.53e-05 | 1005 | 176 | 17 | 19615732 |
| Pubmed | MYH2 TRAPPC11 TRAF2 AUP1 COPB2 RABGAP1 DDB2 RIF1 BANP SNAPC4 RPA1 | 1.56e-05 | 437 | 176 | 11 | 20562859 | |
| Pubmed | 2.28e-05 | 228 | 176 | 8 | 30471916 | ||
| Pubmed | Calpain-dependent alpha-fodrin cleavage at the sarcolemma in muscle diseases. | 2.55e-05 | 2 | 176 | 2 | 15948206 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 37603735 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 31031201 | ||
| Pubmed | Intersectin associates with synapsin and regulates its nanoscale localization and function. | 2.55e-05 | 2 | 176 | 2 | 29078407 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27806939 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 34423028 | ||
| Pubmed | RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer. | 2.55e-05 | 2 | 176 | 2 | 31237864 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 14600265 | ||
| Pubmed | [Analysis of vesicle subpopulations carrying early endosomal autoantigen EEA1]. | 2.55e-05 | 2 | 176 | 2 | 25711083 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23447614 | ||
| Pubmed | The human intersectin genes and their spliced variants are differentially expressed. | 2.55e-05 | 2 | 176 | 2 | 11690630 | |
| Pubmed | Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice. | 2.55e-05 | 2 | 176 | 2 | 22012122 | |
| Pubmed | Genetic mapping of the Rab5a and Rab5b genes on mouse Chromosomes 17 and 2, respectively. | 2.55e-05 | 2 | 176 | 2 | 8835543 | |
| Pubmed | An endosomal tether undergoes an entropic collapse to bring vesicles together. | 2.55e-05 | 2 | 176 | 2 | 27556945 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 18368072 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 8993318 | ||
| Pubmed | Exosome-mediated improvement in membrane integrity and muscle function in dystrophic mice. | 2.55e-05 | 2 | 176 | 2 | 33333294 | |
| Pubmed | The expression of cyclin G in nasopharyngeal carcinoma and its significance. | 2.55e-05 | 2 | 176 | 2 | 21688120 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23022192 | ||
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 2.55e-05 | 2 | 176 | 2 | 11586358 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 21300063 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23936226 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20519134 | ||
| Pubmed | Rab5 and Alsin regulate stress-activated cytoprotective signaling on mitochondria. | 2.55e-05 | 2 | 176 | 2 | 29469808 | |
| Pubmed | A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death. | 2.55e-05 | 2 | 176 | 2 | 27253414 | |
| Pubmed | Comprehensive phenotypic analysis of knockout mice deficient in cyclin G1 and cyclin G2. | 2.55e-05 | 2 | 176 | 2 | 27982046 | |
| Pubmed | Characterisation of human cyclin G1 and G2: DNA damage inducible genes. | 2.55e-05 | 2 | 176 | 2 | 8806701 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 2.55e-05 | 302 | 176 | 9 | 30561431 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL31 MYO1C HLA-B SPTAN1 COPB2 HEATR1 WDR43 SART1 DDX46 GTF2I UBTF DOCK7 RPL22L1 TNFAIP3 RPA1 HERC5 | 2.87e-05 | 949 | 176 | 16 | 36574265 |
| Pubmed | 2.94e-05 | 35 | 176 | 4 | 20943929 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CMBL MYH2 RPL31 TRAF2 MYO1C HLA-B MYCBP2 AUP1 COPB2 ALS2 KPNA6 PSMD11 HEATR1 DERA KMT2C RASGRP1 MAP7D1 GTF2I RAB5A | 3.02e-05 | 1284 | 176 | 19 | 17353931 |
| Pubmed | KPNA5 SPTAN1 KPNA6 EXOSC2 SART1 GTF2F1 DDX46 GTF2I DOCK7 SNAPC4 | 3.26e-05 | 390 | 176 | 10 | 17643375 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 3.56e-05 | 394 | 176 | 10 | 27248496 | |
| Pubmed | LPCAT1 HLA-B APC EXOC3 NLRP1 ATF2 RIF1 MAP7D1 PLXNC1 ITSN2 PKD2 TOP3B | 3.57e-05 | 568 | 176 | 12 | 9110174 | |
| Pubmed | RPL31 RAPGEF6 CYP17A1 ITSN1 COPB2 APC ALS2 CHD7 HEATR1 ATF2 KMT2C UBTF NKAPD1 PLCL2 TNFAIP3 RPA1 SLX4 | 3.96e-05 | 1084 | 176 | 17 | 11544199 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAPGEF6 MYO1C MYCBP2 SPTAN1 ITSN1 CHD7 ATF2 EXOSC2 PPL SART1 RIF1 DDX46 GTF2I SNAPC4 | 4.36e-05 | 774 | 176 | 14 | 15302935 |
| Pubmed | Cell fate decisions regulated by K63 ubiquitination of tumor necrosis factor receptor 1. | 4.45e-05 | 14 | 176 | 3 | 24980434 | |
| Pubmed | 4.45e-05 | 14 | 176 | 3 | 15749123 | ||
| Pubmed | 4.45e-05 | 14 | 176 | 3 | 31300538 | ||
| Pubmed | MYH2 MYO1C AUP1 SPTAN1 COPB2 AGPAT4 PSMD11 HEATR1 MCCC1 EXOSC2 LHX2 IARS2 MAP7D1 DDX46 GTF2I UBTF MRPS26 DOCK7 RPA1 HERC5 | 4.49e-05 | 1440 | 176 | 20 | 30833792 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | ZSWIM8 LCORL KPNA6 CHD7 PSMD11 NUP58 KIF20B GTF2F1 MAP7D1 GTF2I | 5.07e-05 | 411 | 176 | 10 | 35182466 |
| Pubmed | Ascl1 and Gsh1/2 control inhibitory and excitatory cell fate in spinal sensory interneurons. | 5.54e-05 | 15 | 176 | 3 | 16715081 | |
| Pubmed | 5.54e-05 | 15 | 176 | 3 | 16690754 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CMBL MYH3 MYO1C HLA-B DYNC2H1 CAPN1 LCP1 PPL ITSN2 PKD2 PKLR NKX6-1 EEA1 CROCC RAB5B DOP1B | 6.42e-05 | 1016 | 176 | 16 | 19056867 |
| Pubmed | 6.48e-05 | 134 | 176 | 6 | 19030180 | ||
| Pubmed | KPNA5 MYO1C MYCBP2 AUP1 DYNC2H1 COPB2 KPNA6 PSMD11 HEATR1 RIF1 IARS2 MAP7D1 | 6.63e-05 | 606 | 176 | 12 | 36538041 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CMBL RPL31 MYO1C MYCBP2 DYNC2H1 SPTAN1 CAPN1 COPB2 MCCC1 IARS2 ZFHX3 EEA1 RAB5A RAB5B | 6.80e-05 | 807 | 176 | 14 | 30575818 |
| Pubmed | ITSN1 COPB2 ALS2 PSMD11 HEATR1 MCCC1 RIF1 MAP7D1 MRPS26 ITSN2 DOCK7 RPL22L1 DMD RAB5A SPATA13 | 7.11e-05 | 916 | 176 | 15 | 32203420 | |
| Pubmed | HIVEP2 TRIM68 HMX1 ATF2 LHX2 KMT2C GTF2I ZZZ3 PLXNC1 UBTF ZFHX2 ZFHX3 EEA1 | 7.16e-05 | 709 | 176 | 13 | 22988430 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 31718706 | ||
| Pubmed | A splice form of polycystin-2, lacking exon 7, does not interact with polycystin-1. | 7.61e-05 | 3 | 176 | 2 | 16192288 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 22366949 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 14504110 | ||
| Pubmed | Intersectin 2, a new multimodular protein involved in clathrin-mediated endocytosis. | 7.61e-05 | 3 | 176 | 2 | 10922467 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 14701813 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 23656780 | ||
| Interaction | PHF21A interactions | RAPGEF6 MYCBP2 LRRC49 APC CHD7 RABGAP1 NUP58 MCCC1 KIF20B MAP7D1 GTF2I ZZZ3 BANP XRN1 DOCK7 ZFHX3 CHD6 SCLT1 RPA1 | 8.14e-11 | 343 | 168 | 19 | int:PHF21A |
| Interaction | RCOR1 interactions | RAPGEF6 MYCBP2 SPTAN1 LRRC49 TLX3 APC CHD7 RABGAP1 MCCC1 KIF20B TLX1 MAP7D1 DDX46 GTF2I ZZZ3 XRN1 DOCK7 ZFHX3 CHD6 SCLT1 | 5.95e-09 | 494 | 168 | 20 | int:RCOR1 |
| Interaction | SIRT7 interactions | ZSWIM8 DDX31 MYO1C MYCBP2 SPTAN1 CAPN1 COPB2 CHD7 HEATR1 LCP1 WDR43 SART1 RIF1 IARS2 DDX46 GTF2I UBTF XRN1 DOCK7 HERC5 | 4.11e-06 | 744 | 168 | 20 | int:SIRT7 |
| Interaction | HAL interactions | 4.27e-06 | 148 | 168 | 9 | int:HAL | |
| Interaction | HDAC1 interactions | MYH2 RAPGEF6 MYCBP2 SPTAN1 LRRC49 APC KPNA6 PSMD11 RABGAP1 MCCC1 DDB2 KIF20B MAP7D1 GTF2I ZZZ3 UBTF BANP XRN1 DOCK7 NKX2-5 ZFHX3 CROCC RPA1 HERC5 BAHCC1 | 5.40e-06 | 1108 | 168 | 25 | int:HDAC1 |
| Cytoband | 16p13.11 | 1.71e-06 | 23 | 175 | 4 | 16p13.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 2.48e-04 | 426 | 175 | 8 | chr16p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.90e-04 | 346 | 175 | 7 | chr17p13 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 2.47e-08 | 67 | 129 | 8 | 519 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.73e-05 | 53 | 129 | 5 | 532 | |
| GeneFamily | EF-hand domain containing | 1.77e-04 | 219 | 129 | 8 | 863 | |
| GeneFamily | Dyneins, axonemal | 2.24e-04 | 17 | 129 | 3 | 536 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.27e-03 | 66 | 129 | 4 | 722 | |
| GeneFamily | Mannosyl-glycoprotein N-acetylglucosaminyltransferases | 1.76e-03 | 9 | 129 | 2 | 435 | |
| GeneFamily | 1-acylglycerol-3-phosphate O-acyltransferases | 2.66e-03 | 11 | 129 | 2 | 46 | |
| GeneFamily | THAP domain containing | 3.18e-03 | 12 | 129 | 2 | 65 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.56e-03 | 43 | 129 | 3 | 409 | |
| Coexpression | GABRIELY_MIR21_TARGETS | MYCBP2 LCORL APC ALS2 RABGAP1 ATF2 CCNG1 RASGRP1 DDX46 GTF2I ITSN2 PKD2 DMD ACAP2 | 7.41e-09 | 289 | 171 | 14 | M2196 |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 6.75e-06 | 199 | 171 | 9 | M5348 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP2 MYCBP2 ITSN1 RABGAP1 MED13L ATF2 RGS7 KIF20B WDR43 ZZZ3 ITSN2 PKD2 DOP1B | 1.27e-05 | 466 | 171 | 13 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP2 MYCBP2 ITSN1 APC RABGAP1 MED13L ATF2 RGS7 KIF20B WDR43 RIF1 ZZZ3 ITSN2 PKD2 ZFHX3 DMD ACAP2 DOP1B | 1.34e-05 | 856 | 171 | 18 | M4500 |
| Coexpression | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN | 3.58e-05 | 94 | 171 | 6 | M4235 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGDS RPL31 RAPGEF6 HIVEP2 HLA-B MYCBP2 SPTAN1 NLRP1 KPNA6 LCP1 ATF2 CYTIP KMT2C RASGRP1 RIF1 MAP7D1 UBTF CD101 ITSN2 XRN1 TNFAIP3 RPA1 ACAP2 SPATA13 | 4.01e-05 | 1492 | 171 | 24 | M40023 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 4.28e-05 | 194 | 171 | 8 | M7313 | |
| Coexpression | GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 5.12e-05 | 199 | 171 | 8 | M9850 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 5.12e-05 | 199 | 171 | 8 | M5893 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP | 5.31e-05 | 200 | 171 | 8 | M9455 | |
| Coexpression | BENPORATH_EED_TARGETS | GSX1 HLA-B LCORL TLX3 INSRR NKX2-3 GSX2 HMX2 TLX1 ADM LHX2 RASGRP1 LRFN2 GUCY1A1 PLXNC1 NKX2-5 ZFHX3 VWA3B NKX6-1 | 6.65e-05 | 1059 | 171 | 19 | M7617 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 7.88e-05 | 272 | 171 | 9 | M1938 | |
| Coexpression | YIH_RESPONSE_TO_ARSENITE_C2 | 9.42e-05 | 14 | 171 | 3 | M1562 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | LRRC49 AGPAT4 NLRP1 MND1 DDB2 ADM FANCG MSANTD3 MAP7D1 PLCL2 PIMREG GREB1 TNFAIP3 | 9.48e-05 | 567 | 171 | 13 | M45692 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 1.04e-04 | 282 | 171 | 9 | MM822 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.00e-07 | 171 | 175 | 8 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.26e-07 | 185 | 175 | 8 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 9.98e-07 | 193 | 175 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 195 | 175 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 197 | 175 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 197 | 175 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 197 | 175 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 197 | 175 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 197 | 175 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.44e-06 | 172 | 175 | 7 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.87e-06 | 174 | 175 | 7 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.81e-06 | 178 | 175 | 7 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-06 | 180 | 175 | 7 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.76e-06 | 185 | 175 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 9.73e-06 | 188 | 175 | 7 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.04e-05 | 190 | 175 | 7 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.04e-05 | 190 | 175 | 7 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-05 | 191 | 175 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.12e-05 | 192 | 175 | 7 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.12e-05 | 192 | 175 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.15e-05 | 193 | 175 | 7 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.15e-05 | 193 | 175 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.15e-05 | 193 | 175 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 193 | 175 | 7 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.19e-05 | 194 | 175 | 7 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-05 | 194 | 175 | 7 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 129 | 175 | 6 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 195 | 175 | 7 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 195 | 175 | 7 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 195 | 175 | 7 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 195 | 175 | 7 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 195 | 175 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 195 | 175 | 7 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 195 | 175 | 7 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-05 | 195 | 175 | 7 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-05 | 130 | 175 | 6 | 793c42602dde22da0715a5304ea70d791fdd5354 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-05 | 196 | 175 | 7 | 6230b4a26770d30f1ab83345c087f03be1be0f9e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-05 | 196 | 175 | 7 | ff88e5b919b1be93159ad2200a7786d1c5272724 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 77 | 175 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | LPS_only|World / Treatment groups by lineage, cell group, cell type | 1.41e-05 | 199 | 175 | 7 | 852cf595c2255983cff9045f2bb746d4391cf5ba | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-05 | 200 | 175 | 7 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-05 | 200 | 175 | 7 | 79e59ab31d3d3385b1b072dc75508af9546c2e1b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-05 | 200 | 175 | 7 | cf71c3f6281650940f3ade04ea62be3f340bfc68 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.45e-05 | 200 | 175 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-05 | 200 | 175 | 7 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-05 | 200 | 175 | 7 | 873def69bf55ccbfc944bc10c5afc06be019c312 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.45e-05 | 200 | 175 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-05 | 200 | 175 | 7 | 8441e289377215a6877640946fe3f6de1f456502 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.36e-05 | 145 | 175 | 6 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 146 | 175 | 6 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.97e-05 | 151 | 175 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.96e-05 | 159 | 175 | 6 | 6c0ef40f64d2e35eaae3d0002e3c1f22d1239736 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.96e-05 | 159 | 175 | 6 | 745a59c33b04620c5329bdd50e74a8e611f2dc55 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-05 | 160 | 175 | 6 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 162 | 175 | 6 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 162 | 175 | 6 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 165 | 175 | 6 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 166 | 175 | 6 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 166 | 175 | 6 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 166 | 175 | 6 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 6.34e-05 | 173 | 175 | 6 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.34e-05 | 173 | 175 | 6 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.34e-05 | 173 | 175 | 6 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.34e-05 | 173 | 175 | 6 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.34e-05 | 173 | 175 | 6 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.34e-05 | 173 | 175 | 6 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.34e-05 | 173 | 175 | 6 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.34e-05 | 173 | 175 | 6 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.75e-05 | 175 | 175 | 6 | dddeced0cfcf71d03bcf349983908b3bfb0ab51d | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-05 | 176 | 175 | 6 | feafc757e7aa4f17128ff34886beb2fd3461c9ea | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-05 | 176 | 175 | 6 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.19e-05 | 177 | 175 | 6 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.19e-05 | 177 | 175 | 6 | aef050784abbba45c4ab4e8328339c8739c5c453 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-05 | 178 | 175 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.42e-05 | 178 | 175 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 178 | 175 | 6 | cd0c5f15e6b28ce2208346279ee9503d18d9b27d | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 7.42e-05 | 178 | 175 | 6 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 178 | 175 | 6 | 813d121a45e0416de1f26862851f6f0bda7ba43c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 179 | 175 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-05 | 180 | 175 | 6 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.13e-05 | 181 | 175 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.38e-05 | 182 | 175 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 8.38e-05 | 182 | 175 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.64e-05 | 183 | 175 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.90e-05 | 184 | 175 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 9.17e-05 | 185 | 175 | 6 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.17e-05 | 185 | 175 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.17e-05 | 185 | 175 | 6 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 9.17e-05 | 185 | 175 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.17e-05 | 185 | 175 | 6 | 8314dc608bc837df3037e89afd9db39737374ebc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.45e-05 | 186 | 175 | 6 | 903af26a63ec4b1755ab5cb81dfeb8dbd14bc5db | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 9.73e-05 | 187 | 175 | 6 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.73e-05 | 187 | 175 | 6 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.73e-05 | 187 | 175 | 6 | 88f785932e67c613db0dda84496de351359ed962 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.73e-05 | 187 | 175 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.73e-05 | 187 | 175 | 6 | 8896a00b30d11b90ca42726d4e122174a30b161b | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 1.00e-04 | 188 | 175 | 6 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 1.00e-04 | 188 | 175 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 1.00e-04 | 188 | 175 | 6 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 188 | 175 | 6 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | RALGDS TRAF2 DDX31 ITSN1 APC CCNG2 GTF2F1 PKD2 ZFHX3 SNAPC4 RAB5B | 2.70e-07 | 197 | 169 | 11 | 7171_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.94e-07 | 170 | 169 | 10 | 1050_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.17e-06 | 196 | 169 | 10 | 1054_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 6.64e-06 | 175 | 169 | 9 | 1058_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.61e-06 | 178 | 169 | 9 | 1112_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; PC3; HG-U133A | 1.13e-05 | 187 | 169 | 9 | 448_DN | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.46e-05 | 193 | 169 | 9 | 7176_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.86e-05 | 199 | 169 | 9 | 2725_DN | |
| Disease | autoimmune disease | 6.23e-06 | 173 | 165 | 8 | EFO_0005140 | |
| Disease | Sjogren syndrome | 2.19e-05 | 60 | 165 | 5 | EFO_0000699 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.38e-05 | 61 | 165 | 5 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | head and neck cancer (is_marker_for) | 3.11e-05 | 2 | 165 | 2 | DOID:11934 (is_marker_for) | |
| Disease | Sjogren's Syndrome | 4.71e-05 | 13 | 165 | 3 | C1527336 | |
| Disease | Sicca Syndrome | 4.71e-05 | 13 | 165 | 3 | C0086981 | |
| Disease | glycoprotein measurement | 5.75e-05 | 119 | 165 | 6 | EFO_0004555 | |
| Disease | early cardiac repolarization measurement | 5.97e-05 | 14 | 165 | 3 | EFO_0004885 | |
| Disease | diastolic blood pressure, systolic blood pressure | RPL31 DYNC2H1 LRRC49 FADD GSX2 WDR43 RASGRP1 PLXNC1 NKX2-5 ZFHX3 VWA3B CHD6 CROCC | 1.08e-04 | 670 | 165 | 13 | EFO_0006335, EFO_0006336 |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 1.89e-04 | 94 | 165 | 5 | EFO_0008595, EFO_0010351 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 3.16e-04 | 58 | 165 | 4 | EFO_0022338 | |
| Disease | stomach carcinoma (is_marker_for) | 3.19e-04 | 24 | 165 | 3 | DOID:5517 (is_marker_for) | |
| Disease | Ciliopathies | 3.92e-04 | 110 | 165 | 5 | C4277690 | |
| Disease | pancreatic cancer (is_implicated_in) | 4.26e-04 | 112 | 165 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 5.41e-04 | 118 | 165 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | congenital heart disease (implicated_via_orthology) | 6.14e-04 | 69 | 165 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 6.41e-04 | 7 | 165 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | RPL31 HLA-B LCORL AGPAT4 CHD7 LCP1 LRFN2 ZZZ3 NCAN ITSN2 XRN1 DOCK7 | 7.08e-04 | 713 | 165 | 12 | EFO_0005689 |
| Disease | Prostatic Neoplasms | CYP17A1 ITSN1 APC GRB7 CHD7 PPL KMT2C ITSN2 ZFHX3 CHD6 GREB1 | 7.31e-04 | 616 | 165 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | CYP17A1 ITSN1 APC GRB7 CHD7 PPL KMT2C ITSN2 ZFHX3 CHD6 GREB1 | 7.31e-04 | 616 | 165 | 11 | C0376358 |
| Disease | Autoimmune Lymphoproliferative Syndrome | 8.51e-04 | 8 | 165 | 2 | C1328840 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 9.05e-04 | 34 | 165 | 3 | EFO_0009926 | |
| Disease | hypothyroidism | 1.13e-03 | 284 | 165 | 7 | EFO_0004705 | |
| Disease | phosphatidylcholine measurement | 1.13e-03 | 284 | 165 | 7 | EFO_0010226 | |
| Disease | osteoarthritis, hand | 1.16e-03 | 37 | 165 | 3 | EFO_1000789 | |
| Disease | C-reactive protein measurement | MYH2 ZSWIM8 HLA-B LCORL GBX1 CHD7 LCP1 DDB2 PPL GTF2I LRFN2 DNAH17 DOCK7 KCNN3 SNAPC4 KIAA2012 | 1.24e-03 | 1206 | 165 | 16 | EFO_0004458 |
| Disease | hypospadias | 1.35e-03 | 39 | 165 | 3 | EFO_0004209 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0800333 | |
| Disease | temporomandibular joint disorder | 1.36e-03 | 10 | 165 | 2 | EFO_0005279 | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | thyrotoxic periodic paralysis | 1.65e-03 | 11 | 165 | 2 | MONDO_0019201 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.68e-03 | 42 | 165 | 3 | EFO_0022255 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.68e-03 | 224 | 165 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.72e-03 | 225 | 165 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.73e-03 | 153 | 165 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.73e-03 | 153 | 165 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.78e-03 | 154 | 165 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 1.80e-03 | 43 | 165 | 3 | DOID:9261 (is_marker_for) | |
| Disease | Paroxysmal atrial fibrillation | 1.88e-03 | 156 | 165 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.88e-03 | 156 | 165 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.88e-03 | 156 | 165 | 5 | C2585653 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.98e-03 | 12 | 165 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.98e-03 | 12 | 165 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.10e-03 | 96 | 165 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 2.10e-03 | 96 | 165 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | Atrial Fibrillation | 2.10e-03 | 160 | 165 | 5 | C0004238 | |
| Disease | Endometrioma | 2.16e-03 | 161 | 165 | 5 | C0269102 | |
| Disease | Endometriosis | 2.16e-03 | 161 | 165 | 5 | C0014175 | |
| Disease | Parkinson disease | 2.27e-03 | 321 | 165 | 7 | MONDO_0005180 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.33e-03 | 13 | 165 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 40:7 measurement | 2.33e-03 | 13 | 165 | 2 | EFO_0021477 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.33e-03 | 13 | 165 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 2.35e-03 | 99 | 165 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | cholesteryl ester 20:3 measurement | 2.62e-03 | 49 | 165 | 3 | EFO_0010347 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.71e-03 | 14 | 165 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Fanconi anemia | 2.71e-03 | 14 | 165 | 2 | cv:C0015625 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 2.71e-03 | 14 | 165 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | diffuse large B-cell lymphoma | 2.71e-03 | 14 | 165 | 2 | EFO_0000403 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.78e-03 | 50 | 165 | 3 | EFO_0022334 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 2.81e-03 | 104 | 165 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.94e-03 | 51 | 165 | 3 | EFO_0022331 | |
| Disease | Leukemia, Myelocytic, Acute | 2.95e-03 | 173 | 165 | 5 | C0023467 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.11e-03 | 15 | 165 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 3.20e-03 | 255 | 165 | 6 | EFO_0009924 | |
| Disease | remnant cholesterol measurement | 3.22e-03 | 108 | 165 | 4 | EFO_0010815 | |
| Disease | human papilloma virus infection, oropharynx cancer | 3.28e-03 | 53 | 165 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | Alzheimer's disease (is_marker_for) | 3.33e-03 | 257 | 165 | 6 | DOID:10652 (is_marker_for) | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.44e-03 | 110 | 165 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.44e-03 | 110 | 165 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | Acute Cerebrovascular Accidents | 3.46e-03 | 54 | 165 | 3 | C0751956 | |
| Disease | cutaneous psoriasis measurement, psoriasis | 3.54e-03 | 16 | 165 | 2 | EFO_0000676, EFO_0007773 | |
| Disease | coronary artery disease, factor VII measurement | 3.55e-03 | 111 | 165 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | Antithrombotic agent use measurement | 3.64e-03 | 55 | 165 | 3 | EFO_0009925 | |
| Disease | behavior | 3.64e-03 | 55 | 165 | 3 | GO_0007610 | |
| Disease | sex interaction measurement, inflammatory bowel disease | 3.64e-03 | 55 | 165 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | Nasal Cavity Polyp | 3.64e-03 | 55 | 165 | 3 | EFO_1000391 | |
| Disease | myocardial infarction | 3.66e-03 | 350 | 165 | 7 | EFO_0000612 | |
| Disease | factor VIII measurement, coronary artery disease | 3.78e-03 | 113 | 165 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | essential hypertension, age at diagnosis | 3.83e-03 | 56 | 165 | 3 | EFO_0004918, MONDO_0001134 | |
| Disease | Herpes Zoster | 4.00e-03 | 17 | 165 | 2 | EFO_0006510 | |
| Disease | factor XI measurement, coronary artery disease | 4.03e-03 | 115 | 165 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | Liver Cirrhosis, Experimental | FMO1 MYO1C CYP17A1 SPTAN1 LCP1 IFNGR1 CCNG1 ADM PKD2 PKLR DOCK7 | 4.33e-03 | 774 | 165 | 11 | C0023893 |
| Disease | omega-3 polyunsaturated fatty acid measurement | 4.41e-03 | 118 | 165 | 4 | EFO_0010119 | |
| Disease | Bone marrow hypocellularity | 4.48e-03 | 18 | 165 | 2 | C1855710 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 4.65e-03 | 60 | 165 | 3 | EFO_0022237 | |
| Disease | psoriasis vulgaris | 4.87e-03 | 61 | 165 | 3 | EFO_1001494 | |
| Disease | triglycerides in small HDL measurement | 5.10e-03 | 62 | 165 | 3 | EFO_0022158 | |
| Disease | Cerebrovascular accident | 5.10e-03 | 62 | 165 | 3 | C0038454 | |
| Disease | angina pectoris | 5.41e-03 | 125 | 165 | 4 | EFO_0003913 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 5.56e-03 | 126 | 165 | 4 | EFO_0004611, EFO_0010351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RIKQSIDSKCRTAWR | 306 | Q8N9N5 | |
| WTNKNLIVVDDVRKS | 251 | Q9UKF5 | |
| SKGIERINASKWRTL | 221 | B9A014 | |
| LLSWSAVAQTKRKAV | 2126 | Q9P281 | |
| WRQQKEKIALSRETE | 271 | O00478 | |
| QEKTKWLRAISQAVD | 991 | Q96Q42 | |
| VSRVVKLWRENLSKV | 766 | P35606 | |
| ARDWSRKLTQRIKSN | 176 | O95267 | |
| DKKVNRQSARLWETS | 891 | Q9P0K1 | |
| KKLVWIVSRRTAQNL | 266 | Q16589 | |
| ASRCRQKRKVWVQSL | 366 | P15336 | |
| QLSKRWREIESKFAQ | 1951 | P11532 | |
| LQADSEKLRQAWIKA | 341 | Q15057 | |
| AEQSRAAINKWVSNK | 211 | P01008 | |
| DALKSRTIRKWNTTL | 356 | P07384 | |
| EQVTVKKFRTWAERR | 451 | Q8WYQ5 | |
| FRTKTAALKQRWEQL | 56 | A6NFT4 | |
| EAIISEKRQKWTRRE | 1956 | Q9P2D1 | |
| TARLDVASEFRKKWN | 21 | P35318 | |
| QKAEFRTRKEAAWAI | 391 | O15131 | |
| WRTAEAKLVQNTEKL | 126 | O75901 | |
| ESFARAKNWVKELQR | 106 | P20339 | |
| ETFARAKTWVKELQR | 106 | P61020 | |
| TDNINERTAWVQKIK | 1526 | Q9NZM3 | |
| KAITAKVVSLANRLW | 841 | Q17RG1 | |
| IFTLWRQVETKVRAK | 106 | Q9UND3 | |
| NVQKLKWIVSGRTAR | 261 | P51959 | |
| EVQAAKKTWFNRTLS | 1041 | Q9Y3P9 | |
| RLKEQEQKQRSWATG | 476 | Q9C0D6 | |
| ILQKAEFRTRKEAAW | 386 | O60684 | |
| RAVLRVSSTQGKWKA | 236 | Q8NH92 | |
| TLRNAEVKSAIRKLW | 286 | Q96R67 | |
| TVEEIKRRAQSNGKW | 186 | Q8NF37 | |
| VVRLATKWCQRKLQA | 26 | Q14667 | |
| KQIAKLWRKASSQER | 1676 | Q8NEZ4 | |
| NWDDKSIRQAFIRKV | 151 | Q7Z429 | |
| WKECILNRTQSKRSQ | 381 | Q71F56 | |
| DAIQKKRTGRTWENI | 1336 | Q71F56 | |
| EWRLSFARSEVQLKK | 286 | Q8IYB1 | |
| LRKWSSKTRASEVQE | 1696 | Q4ZG55 | |
| QLTAAVAAVWSRKKA | 1686 | Q9Y3R5 | |
| LWARAQAERTEKSKL | 351 | Q8N3X6 | |
| RKNISVWCKQAEEIR | 356 | Q16206 | |
| KRTKRLTAQWALAAQ | 256 | Q3V5L5 | |
| LSEKQVKIWFQNRRV | 241 | Q9BZM3 | |
| IVNWVNETLREAKKS | 521 | P13796 | |
| IQARAKRVSWDFKTA | 336 | O60486 | |
| KRIKNAAANVLRETW | 566 | Q9UGI6 | |
| VLRIRSAQAWKKALA | 226 | Q8NHB1 | |
| RQANKVAKEAANRWT | 156 | Q9BWT6 | |
| EKSINRKRLWNFTEE | 116 | Q5SWX8 | |
| ALSKANTEVAQWRTK | 1366 | Q9UKX2 | |
| ASQREKTELLRKIWA | 1146 | O60437 | |
| KEKTTWVDVVNRRLV | 176 | Q9H5P4 | |
| IRAFRLVKSNKELWA | 501 | Q9C000 | |
| QAWLKKRTAQEAAVF | 2276 | Q96JB1 | |
| NKWKRQLAAELEAAS | 256 | Q9NP08 | |
| RNKWKRQLSAELEAA | 201 | A2RU54 | |
| LSEKQVKIWFQNRRV | 186 | Q9H4S2 | |
| KILNVKRATISWENS | 511 | Q96Q89 | |
| TKREQEKASWDRLRA | 976 | Q0VF49 | |
| EKKRLTINNVARQWD | 336 | Q8IUZ0 | |
| QLRSWVSKSQRDLAK | 11 | P30613 | |
| TKRVLQVWFQNARAK | 306 | P50458 | |
| KSDARTIALKQRTWQ | 36 | Q96H12 | |
| WREKNDRLVRQAKVA | 16 | O15287 | |
| IFTLWRQVETKVRAK | 106 | F8WFD2 | |
| LRNKEVKEALRQTWS | 296 | Q8NGR4 | |
| KIWQNLRLKTAAAAA | 226 | P30559 | |
| SGTKWLVETQVKARR | 106 | Q9BSJ6 | |
| TVKIWDLRQVRGKAS | 266 | Q92466 | |
| RRVSWAKKALQSFIQ | 706 | Q9H8H2 | |
| FTLWRQVETKVRAKI | 126 | E9PIF3 | |
| VQQKRWKVETNSRLD | 91 | Q13868 | |
| DTAAQITQRKWEAAR | 161 | P01889 | |
| KLTSTQVKIWFQNRR | 176 | P52952 | |
| ALSVALEEAQAWRKK | 391 | Q14451 | |
| AEASQKLASWRIKQV | 221 | A6NG13 | |
| VVIWARRKDAQDQAK | 1361 | Q7Z442 | |
| KRWQSTKREIQEIFS | 406 | Q9UII4 | |
| SVKKRIVVAARDNWA | 1311 | Q96JP2 | |
| KLLNKRTWQREISRA | 461 | Q9NQV7 | |
| KWTICARVTNKSQIR | 196 | P27694 | |
| ARALAIQNWVDKAEK | 4146 | Q8NCM8 | |
| GTVKKEWQSSQRRVS | 1251 | Q15075 | |
| DIRKVTNDWTRCRKE | 256 | Q5TZA2 | |
| AFSVWRKNVRSKKIT | 281 | Q9C0G6 | |
| SEVQVKIWFQNRRAK | 301 | Q14549 | |
| KSRNQARDLSWTQKI | 516 | Q93033 | |
| TLRSNTRKEKALWVD | 986 | Q93033 | |
| WRQNTEKLDKSRAEI | 1451 | Q96N67 | |
| SSWIERRKVQSEKAN | 2276 | Q9UFH2 | |
| LINKEAQKRWTRREQ | 1441 | Q8TD26 | |
| WRNSKEKEVLSNRCI | 241 | Q6ZNG2 | |
| VKIKVRQAWREAQAE | 491 | P05093 | |
| QWDRTFKVIKARVVQ | 491 | Q01740 | |
| INERTAWVQKIKAAS | 1556 | Q15811 | |
| VRESLRIWKNTEKEN | 141 | Q13158 | |
| SWSQRKLVTVEKQDN | 71 | O60759 | |
| LRTKKNTAIVKRWSD | 656 | Q12967 | |
| KLVVWAADRQAALTK | 436 | Q96RQ3 | |
| QRSVKKTWAEIRQQR | 216 | Q3KQU3 | |
| KVAWEASSKNSVLLR | 821 | P14616 | |
| EVQLWDVVTKKRLRN | 296 | Q86Y33 | |
| RQQWESRERKKITDS | 306 | Q8NEP3 | |
| ERNADKLTVKFWRAL | 1566 | Q9H583 | |
| VSRLWSKSAVQNKVV | 26 | A6NNS2 | |
| RWKVTSKEALQRISE | 946 | Q7L014 | |
| WRQSINTIESLKDVK | 86 | O60645 | |
| FEKWNARITDLRKQV | 351 | P78347 | |
| LNKRTRRSIQKLIEW | 166 | Q5VXU3 | |
| AWVQVKSERSRNSRK | 651 | Q14147 | |
| QIQARRTVKKEWQAA | 31 | Q9Y315 | |
| KLTSTQVKIWFQNRR | 186 | Q8TAU0 | |
| NSLWVRVKARVGQKE | 96 | P15260 | |
| VFETRRAEAKKWQNT | 431 | Q9BVL2 | |
| RAEAKKWQNTPRVTT | 436 | Q9BVL2 | |
| QAVLRINSATAWRKA | 221 | Q9GZK4 | |
| IFTLWRQVETKVRAK | 106 | E9PJI5 | |
| IFTLWRQVETKVRAK | 106 | P0DM63 | |
| RKAEEVQAWAQRKER | 141 | Q9BYN8 | |
| TWNQARLERDLSNKK | 41 | P35269 | |
| NFIAWVKRQKISSAD | 31 | P59543 | |
| FIALVNSTEWVKRQK | 26 | P59539 | |
| LEASKEPSQQRVKRW | 316 | P49802 | |
| AKWRQVVLQKASRES | 526 | Q8TEU7 | |
| LKNTWSENKLSRRQT | 471 | Q92733 | |
| TESQVKVWFQNRRTK | 276 | P78426 | |
| IFTLWRQVETKVRAK | 106 | E9PKD4 | |
| SDKNVRTRALWVISK | 111 | Q5UIP0 | |
| WAKSEKRTFLRQALE | 116 | O00231 | |
| IKWTKVRTASGQRQD | 76 | O14594 | |
| RKLQKAVESFTWNIT | 1051 | Q9UPR0 | |
| ALSKANSEVAQWRTK | 1361 | P11055 | |
| NSTSRIRNRKEKKSW | 401 | O75592 | |
| RASKQWFINITDIKT | 476 | Q9NSE4 | |
| QAPRTKKQRVTKWQA | 116 | Q8IY92 | |
| LSWRADVNSKKTLRE | 551 | P25054 | |
| EWLKTRNAQKIDREI | 96 | Q96DG6 | |
| QSVSLTIWKKAVERL | 211 | Q9NQ32 | |
| AKSSWARQESLQERK | 376 | Q9Y679 | |
| EIQERTNKRTNWKVA | 266 | Q6ZUT1 | |
| TNKRTNWKVATDERS | 271 | Q6ZUT1 | |
| RKLESIDKIARWQVS | 426 | Q96N96 | |
| WKISDFARKRQEAVA | 356 | Q12933 | |
| WVLQAKVNTDKDRSL | 241 | O95985 | |
| QKKKSNWRSTTRLRI | 76 | Q7M4L6 | |
| ERKRTATWKIQVETR | 166 | Q6AZZ1 | |
| KRKWLRQEASIQALT | 26 | A2A3L6 | |
| LAVKTAQKLWADRIS | 556 | Q7Z392 | |
| LKKRVVQVWFQNTRA | 1896 | Q9C0A1 | |
| KKNNLRDWLRVVASD | 86 | Q6P5R6 | |
| DVRIDTRLNKAVWAK | 61 | P62899 | |
| LQRAKSALEVVWNKS | 801 | Q8NB66 | |
| TLESQKKLNWCREVR | 76 | P21580 | |
| QRSLVNKWTTFLKAR | 276 | Q13214 | |
| QRVLEKQWTSFLKAR | 266 | Q9H2E6 | |
| KWEALKAKASQRRQD | 871 | Q13813 | |
| LARQLQDFWKKSRNT | 111 | Q969T3 | |
| AWRVDINKNKITRID | 636 | Q8IZH2 | |
| LATQQKAANRWKEET | 581 | Q96NL6 | |
| VASLKKNVWLDRGTR | 406 | Q13563 | |
| AAWIERSRQLQKEKD | 201 | O43290 | |
| TDAQVKTWFQNRRTK | 206 | O43711 | |
| KRSKQTKELWQRVSL | 1816 | A7E2V4 | |
| TDAQVKTWFQNRRTK | 241 | P31314 | |
| NWEKALLRKSVVSDR | 186 | Q5SXM2 | |
| RKWEQDRKTVATSLQ | 146 | Q9NRZ5 | |
| RATRRWIKATCLVKN | 161 | Q9H0W7 | |
| KRLNKIVWRALSQEE | 931 | Q502W6 | |
| KWVEISNEVRKFRTL | 71 | P17480 | |
| KASGRWRQEQSAVIK | 21 | P31629 | |
| LKQQSTRESWVSPRK | 71 | Q8IYH5 | |
| DSKRLIQWLKAVQRD | 31 | Q8WY91 | |
| LNVWQVRSENKEKSA | 246 | Q15061 | |
| KKRVVQVWFQNTRAR | 2681 | Q15911 | |
| FVVRVRRWDNSVKKS | 346 | Q02108 | |
| RKVSNIWTKRSLSVN | 746 | Q9ULH4 | |
| IWAQRKENESSSLIK | 676 | Q9C099 | |
| EVRRQSLATKIQAAW | 731 | O00159 | |
| RQLWKKSVDSIRQDS | 1011 | Q12879 |